Efficacy and Safety of MCS-5 in Treating Male Oligoasthenospermia

Update Il y a 4 ans
Reference: NCT01016340

Extract

This is a phase II randomized, double-blind, placebo-controlled study where eligible subfertile male subjects (age 20 years).


Inclusion criteria

  • Male Oligoasthenospermia

Links